EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity

Júlia Carmona-Maurici, Araceli Rosa iD, Natalia Azcona-Granada, Elionora Peña, David Ricart-Jané, Anna Viñas, Maria Dolores López-Tejero, Joan Carles Domingo iD, Antonio Miñarro, Juan Antonio Baena-Fustegueras, Julia Peinado-Onsurbe, Eva Pardina iD

International Journal of Molecular Sciences · 03.05.2023 · 24 (9) · 8171

DOI: 10.3390/ijms24098171 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.05.2023. Verfasst von Júlia Carmona-Maurici und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 643, 08028 Barcelona, Spain. Hauptthemen laut MEDLINE: Obesity, Morbid, Plaque, Atherosclerotic, Atherosclerosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Carlos III Institute of Health (ISCIII), EU FEDER Programme (European Regional Development Fund: “Una manera de hacer Europa”).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe obesity (SO) can accelerate atherosclerosis and the onset of acute cardiovascular events. The diagnosis of atherosclerosis in the context of a high body mass index (BMI) can be challenging, making the identification of biomarkers clinically relevant. We aimed to assess the usefulness of irisin as a biomarker for subclinical atherosclerosis in participants with SO. This prospective observational study included 61 participants undergoing bariatric surgery for SO, defined as a BMI >40 kg/m2 or >35 kg/m2 with at least one comorbidity. Atherosclerotic plaques were detected by ultrasound. Plasma samples were obtained 1 month before and at 6 and 12 months after bariatric surgery to measure irisin by ELISA. Additionally, subcutaneous samples of adipose tissue were taken and genotyped to identify irisin polymorphism rs3480. Irisin levels were positively correlated with BMI (r = 0.23, p = 0.0064), negatively correlated with atheroma-related parameters (e.g., carotid intima-media thickness), and lower in subjects with atheroma (p < 0.0002). Irisin also showed good overall accuracy for discriminating plaque presence (AUC, 0.81; 95% CI, 0.6956–0.9156). However, the rs3480 polymorphism correlated with neither the irisin levels nor the presence of atheromas. Iirisin could identify subclinical atherosclerosis in SO and might facilitate clinical diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obesity, MorbidPlaque, AtheroscleroticAtherosclerosisHumansFibronectinsCarotid Intima-Media ThicknessObesityBiomarkers

Stichwörter der Autor:innen

FNDC5 genebariatric surgerygenetic variabilityirisinmetabolic disordersrs3480severe obesitysubclinical atherosclerosis

Substanzen

FibronectinsBiomarkers

Autor:innen und Institutionen

  • Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 643, 08028 Barcelona, Spain.
  • Secció de Zoologia i Antropologia Biològica, Departament de Biologia Evolutiva Ecologia i Ciències Ambientals Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain.
  • Institut de Biomedicina de la Universitat de Barcelona (IBUB), 08028 Barcelona, Spain.
  • Centre for Biomedical Research Network on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Barcelona, Spain.
  • Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain.
  • Gastrointestinal Surgery Department, Arnau de Vilanova University Hospital, IRB Lleida, University of Lleida, 25198 Lleida, Spain.

ORCID-Profile: Araceli Rosa, Joan Carles Domingo, Eva Pardina

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Sanidad y Consumo, Carlos III Institute of Health (ISCIII)
  • EU FEDER Programme (European Regional Development Fund: “Una manera de hacer Europa”)

Zitieren

APA

Carmona-Maurici, J., Rosa, A., Azcona-Granada, N., Peña, E., Ricart-Jané, D., Viñas, A., López-Tejero, M. D., Domingo, J. C., Miñarro, A., Baena-Fustegueras, J. A., Peinado-Onsurbe, J., & Pardina, E. (2023). Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity. International Journal of Molecular Sciences, 24(9), 8171. https://doi.org/10.3390/ijms24098171

Vancouver

Carmona-Maurici J, Rosa A, Azcona-Granada N, Peña E, Ricart-Jané D, Viñas A, et al. Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity. International Journal of Molecular Sciences. 2023;24(9):8171. doi:10.3390/ijms24098171

BibTeX
@article{CarmonaMaurici2023,
  author = {Carmona-Maurici, Júlia and Rosa, Araceli and Azcona-Granada, Natalia and Peña, Elionora and Ricart-Jané, David and Viñas, Anna and López-Tejero, Maria Dolores and Domingo, Joan Carles and Miñarro, Antonio and Baena-Fustegueras, Juan Antonio and Peinado-Onsurbe, Julia and Pardina, Eva},
  title = {Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {8171},
  doi = {10.3390/ijms24098171}
}
Kostenlos starten →